180 related articles for article (PubMed ID: 7222603)
21. [The efficacy of ticlid in treating intermittent claudication in atherosclerotic stenosis of the arteries of the lower extremities].
Kirichenko AA; Prekina VI; Repinskaia NP; Novichkova IuN; Ter-Gevondian NM; Vinogradova IV
Ter Arkh; 1994; 66(12):23-6. PubMed ID: 7900036
[TBL] [Abstract][Full Text] [Related]
22. [Preliminary study on erythrocyte filterability and other hemorrheological parameters in arteriosclerotic vascular disease].
Pernigotti L; Neirotti M
Ric Clin Lab; 1983; 13 Suppl 3():423-6. PubMed ID: 6673024
[TBL] [Abstract][Full Text] [Related]
23. [Critical review of clinical experimentation with clofibrate in coronary disease].
Azzena D; Astengo F
Minerva Cardioangiol; 1973; 21(7):497-502. PubMed ID: 4756344
[No Abstract] [Full Text] [Related]
24. [Blood viscosity in angina pectoris and acute myocardial infarct].
Belousov IuB; Liusov VA; Zakharchenko VN; Larionov SM; Chuev IuV
Kardiologiia; 1973 Mar; 13(3):5-10. PubMed ID: 4780477
[No Abstract] [Full Text] [Related]
25. [The occurence of same coronary disease risk factors in the group of men with intermittent claudication (author's transl)].
Hartwich A; Kowal S; Magdoń M; Mlodkowska K; Nowacki G
Przegl Lek; 1977; 34(8):691-6. PubMed ID: 928820
[No Abstract] [Full Text] [Related]
26. [Effect of adrenergic beta receptor blockaders on blood viscosity after their short-term use in patients with arteriosclerosis].
Turczyński B; Znamirowska D
Pol Tyg Lek; 1985 Apr; 40(17):481-4. PubMed ID: 4011500
[No Abstract] [Full Text] [Related]
27. [Rheologic observations on blood viscosity in atherosclerosis (with dyslipidosis and peripheral obliterating arteriopathy)].
Alberto S; Biasci R; Naldi R; Picco S; Dughera L
Minerva Cardioangiol; 1977; 25(7-8):629-35. PubMed ID: 927655
[No Abstract] [Full Text] [Related]
28. [Blood viscosity in coronary occlusion].
Pedersen T; Persson I
Ugeskr Laeger; 1967 Nov; 129(44):1480-2. PubMed ID: 5594982
[No Abstract] [Full Text] [Related]
29. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].
Cucinotta D; Ferretti PG; Daccò L; Mazzera F
G Clin Med; 1977; 58(11-12):475-86. PubMed ID: 608558
[No Abstract] [Full Text] [Related]
30. A double-blind placebo controlled crossover study in patients with peripheral vascular diseases, using a new capillary viscometer.
Weber G; Kreisel T; Peter S; Künzel J
Angiology; 1980 Jan; 31(1):1-5. PubMed ID: 7369533
[No Abstract] [Full Text] [Related]
31. [Takata-Ara and Weltmann's reactions in patients over 50 with hypertensive disease and coronary arteriosclerosis].
Fesenko IP
Vrach Delo; 1973 Jun; 6():33-5. PubMed ID: 4755126
[No Abstract] [Full Text] [Related]
32. [Effects of clofibrate on fibrinolysis and platelet adhesiveness and aggregation in patients with arteriosclerosis].
Cajozzo A; Abbadessa V; Carreca I; Perricone R
Boll Soc Ital Cardiol; 1973; 18(4):361-7. PubMed ID: 4807075
[No Abstract] [Full Text] [Related]
33. Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate.
Postlethwaite JC; Dormandy JA
Ann Surg; 1975 Jun; 181(6):799-802. PubMed ID: 1138629
[TBL] [Abstract][Full Text] [Related]
34. Importance of blood viscosity. Rheological claudication.
Dormandy JA; Hoare E; Postlethwaite J
Proc R Soc Med; 1974 Jun; 67(6 Pt 1):446-7. PubMed ID: 4852367
[No Abstract] [Full Text] [Related]
35. [Changes of the electrophoretic tracing of the serum glycoproteins in arteriosclerotic patients treated with clofibrate].
Notarbartolo A; Rini GB; Campisi D
Boll Soc Ital Cardiol; 1973; 18(4):373-8. PubMed ID: 4807077
[No Abstract] [Full Text] [Related]
36. Cigarette smoking as a risk factor for atherosclerosis. Study of the biologic changes consecutive to smoking in normals, in patients with coronary heart disease and in diabetics.
Bornemisza P; Major G; Suciu I; Major I
Med Interne; 1981; 19(3):251-8. PubMed ID: 7302504
[TBL] [Abstract][Full Text] [Related]
37. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
Laursen B; Gormsen J
Scand J Haematol; 1969; 6(6):402-8. PubMed ID: 5374117
[No Abstract] [Full Text] [Related]
39. [Characteristics of blood rheological disorders in hypertension and ischemic heart disease].
Lapotnikov VA; Kharash LM
Ter Arkh; 1984; 56(4):75-8. PubMed ID: 6729735
[No Abstract] [Full Text] [Related]
40. Hypothesis of viscoreceptors: malfunction of viscoreceptors and viscosity-controllers in hypertension and polycythaemia.
Dintenfass L
Bibl Anat; 1977; (16 Pt 2):478-80. PubMed ID: 603588
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
